Results 161 to 170 of about 31,178 (269)

Supplementary Figure 2 from Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors

, 2023
Hiroaki Wakimoto, Santosh Kesari, Christopher J. Farrell, William T. Curry, Cécile Zaupa, Manish K. Aghi, Toshihiko Kuroda, Anat Stemmer‐Rachamimov, Khalid Shah, Ta‐Chiang Liu, Deva S. Jeyaretna, Jason Debasitis, Jan Pruszak, Robert L. Martuza, Samuel D. Rabkin   +14 more
openalex   +1 more source

Advancements on the synergistic application of oncolytic viruses and molecularly targeted therapies for the treatment of solid tumors (Review). [PDF]

Int J Oncol
Bi S, Shan T, Tang Y, Wang Q.
europepmc   +1 more source

171. Induction of Anti-Tumor Immunity to Murine Neuroblastoma by Flt3-Ligand Generated-Dendritic Cells Loaded with Oncolytic Herpes Simplex Virus-Infected Cells [PDF]

, 2008

openalex   +1 more source

Supplementary Data from Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy

, 2023
Carmela Passaro, Quazim A. Alayo, Isabel DeLaura, John A. McNulty, Korneel Grauwet, Hirotaka Ito, Vivek Bhaskaran, Marco Mineo, Sean Lawler, Khalid Shah, Maria C. Speranza, William F. Goins, Eric McLaughlin, Soledad Fernández, David A. Reardon, Gordon J. Freeman, E. Antonio Chiocca, Hiroshi Nakashima   +17 more
openalex   +1 more source

Design and Efficacy of Oncolytic Viruses and Antitumor Vaccines: A Dead End in the Immunotherapy of Pancreatic Cancer? [PDF]

Int J Mol Sci
Achim E, Pîrlici E, Cristea C, Tertis M.   +3 more
europepmc   +1 more source

Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB–D melanoma: a phase 1/2 trial [PDF]

Reinhard Dummer, Caroline Robert, Richard A. Scolyer, Janis M. Taube, Michael T. Tetzlaff, Alexander M. Menzies, Andrew F. Hill, Jean‐Jacques Grob, David C. Portnoy, Célèste Lebbé, Muhammad A. Khattak, Jonathan Cohen, Gil Bar‐Sela, Inderjit Mehmi, Ronnie Shapira‐Frommer, Nicolás Meyer, Andrea L. Webber, Yixin Ren, Mizuho Fukunaga‐Kalabis, Clemens Krepler, Georgina V. Long   +20 more
openalex   +1 more source

Oncolytic viruses targeting CD47: a new road to success? [PDF]

J Immunother Cancer
Takimoto CH, Wick MJ.
europepmc   +1 more source

Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells

, 2014
James J. Cody, James M. Markert, Douglas R. Hurst   +2 more
openalex   +2 more sources

Next-Generation Oncolytic Viruses to Overcome Resistance to Anti-PD-1 Therapy in Melanoma. [PDF]

J Clin Oncol
McArthur GA.
europepmc   +1 more source

A new strategy for melanoma treatment: an investigation of the clinical value of the combination of immune checkpoint inhibitors and oncolytic viruses. [PDF]

Cancer Cell Int
Sui B, Jin X, Zheng X.
europepmc   +1 more source